Trends in antimicrobial prescribing rates for children and adolescents

Linda F McCaig1, Richard E Besser, James M Hughes

  • 1Ambulatory Care Statistics Branch, Division of Health Care Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, 6525 Belcrest Rd, Room 952, Hyattsville, MD 20782, USA. lfm1@cdc.gov

JAMA
|June 19, 2002
PubMed
Abstract

Insights

Antimicrobial prescribing for children decreased significantly from 1989-2000, with notable reductions for respiratory infections. This study highlights successful efforts to curb inappropriate antimicrobial use in pediatric care.

Area of Science:

  • Pediatric Health
  • Infectious Diseases
  • Public Health Policy

Background:

  • Antimicrobial prescribing rates for children increased significantly from 1980 to 1992.
  • Rising antimicrobial resistance in the 1990s was linked to increased antimicrobial use.
  • Public health initiatives aimed to promote appropriate antimicrobial prescribing to combat resistance.

Purpose of the Study:

  • To evaluate changes in antimicrobial prescribing rates in children and adolescents younger than 15 years.
  • To specifically assess prescribing trends for common respiratory tract infections.

Main Methods:

  • Analysis of National Ambulatory Medical Care Survey data from 1989-1990 to 1999-2000.
  • Inclusion of data from 2500-3500 office-based physicians and 6500-13,600 pediatric visits per period.
  • Examination of population- and visit-based prescribing rates for overall and specific respiratory infections.

Main Results:

  • Overall population-based prescribing rates decreased from 838 to 503 per 1000 children (P <.001).
  • Visit-based prescribing rates dropped from 330 to 234 per 1000 visits (P <.001).
  • Significant declines were observed for pharyngitis and upper respiratory infections, with mixed results for otitis media and bronchitis, and stable rates for sinusitis.

Conclusions:

  • Antimicrobial prescribing rates for children and adolescents significantly decreased between 1989-1990 and 1999-2000.
  • These findings indicate a successful reduction in antimicrobial use for pediatric respiratory conditions.
  • The study underscores the impact of public health efforts on antimicrobial stewardship in pediatric care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
704
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
738
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K